Holdings Channel
Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Email EnvelopeFree SVRA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Other companies seeing insider buying close in time to when the SVRA Insider Buying occurred are:

BMC Insider Buying
EQS Insider Buying
PGZ Insider Buying
LMT Insider Buying
ACGN Insider Buying
THRX Insider Buying
BYD Insider Buying
SLGD Insider Buying
MLKN Insider Buying
SCY Insider Buying

SVRA insider buying image
The table below summarizes the most recent SVRA insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why SVRA insider buys are important for investors to follow.
DateInsiderPriceAmount
7-17-2023
Insider Buy
Growth Equity Opportunities 17, LLC
>10% Owner
$3.00
CAGR »
$999,999.00
333,333 shares
7-17-2023
Insider Buy
Forest Baskett
>10% Owner
$3.00
CAGR »
$999,999.00
333,333 shares
7-17-2023
Insider Buy
Ali Behbahani
>10% Owner
$3.00
CAGR »
$999,999.00
333,333 shares
7-17-2023
Insider Buy
Carmen Chang
>10% Owner
$3.00
CAGR »
$999,999.00
333,333 shares
7-17-2023
Insider Buy
Anthony A. Florence Jr.
>10% Owner
$3.00
CAGR »
$999,999.00
333,333 shares
7-17-2023
Insider Buy
Mohamad Makhzoumi
>10% Owner
$3.00
CAGR »
$999,999.00
333,333 shares
7-17-2023
Insider Buy
Edward T. Mathers
>10% Owner
$3.00
CAGR »
$999,999.00
333,333 shares
7-17-2023
Insider Buy
Scott D. Sandell
>10% Owner
$3.00
CAGR »
$999,999.00
333,333 shares
7-17-2023
Insider Buy
Paul Edward Walker
>10% Owner
$3.00
CAGR »
$999,999.00
333,333 shares
7-17-2023
Insider Buy
Rick Yang
>10% Owner
$3.00
CAGR »
$999,999.00
333,333 shares
6-26-2023
Insider Buy
Raymond Dennis Pratt
Chief Medical Officer
$2.93
CAGR »
$19,045.00
6,500 shares
5-26-2023
Insider Buy
David A. Ramsay
Director
$2.59
CAGR »
$258,528.94
100,000 shares
12-30-2022
Insider Buy
David A. Ramsay
Director
$1.54
CAGR »
$55,586.00
36,000 shares
12-28-2022
Insider Buy
David A. Ramsay
Director
$1.45
CAGR »
$27,588.24
19,000 shares
12-22-2022
Insider Buy
David A. Ramsay
Director
$1.48
CAGR »
$66,434.34
45,000 shares
12-22-2022
Insider Buy
Raymond Dennis Pratt
Chief Medical Officer
$1.54
CAGR »
$5,401.90
3,500 shares
12-20-2022
Insider Buy
David A. Ramsay
Director
$1.50
CAGR »
$82,104.52
54,890 shares
11-23-2022
Insider Buy
David A. Ramsay
Director
$1.43
CAGR »
$28,652.19
20,105 shares
9-27-2022
Insider Buy
David A. Ramsay
Director
$1.39
CAGR »
$187,093.28
135,000 shares
9-20-2022
Insider Buy
David A. Ramsay
Director
$1.45
CAGR »
$11,561.80
8,000 shares
9-8-2022
Insider Buy
David A. Ramsay
Director
$1.40
CAGR »
$44,721.65
32,000 shares
9-1-2022
Insider Buy
David A. Ramsay
Director
$1.42
CAGR »
$141,931.84
100,000 shares
6-22-2022
Insider Buy
David A. Ramsay
Director
$1.38
CAGR »
$138,380.08
100,000 shares
12-30-2021
Insider Buy
David A. Ramsay
Director
$1.28
CAGR »
$64,035.00
50,000 shares
12-17-2021
Insider Buy
David L. Lowrance
CHIEF FINANCIAL OFFICER
$1.14
CAGR »
$4,568.80
4,000 shares
12-17-2021
Insider Buy
David A. Ramsay
Director
$1.11
CAGR »
$44,485.00
40,000 shares
12-10-2021
Insider Buy
David A. Ramsay
Director
$1.04
CAGR »
$36,365.00
35,000 shares
12-8-2021
Insider Buy
David A. Ramsay
Director
$1.05
CAGR »
$26,214.47
25,000 shares
12-9-2021
Insider Buy
Badrul A. Chowdhury
CHIEF MEDICAL OFFICER
$1.05
CAGR »
$26,250.00
25,000 shares
12-8-2021
Insider Buy
Matthew Pauls
CHIEF EXECUTIVE OFFICER
$1.06
CAGR »
$6,889.35
6,500 shares
12-2-2021
Insider Buy
Matthew Pauls
CHIEF EXECUTIVE OFFICER
$1.10
CAGR »
$10,954.00
10,000 shares
12-1-2021
Insider Buy
David A. Ramsay
Director
$1.09
CAGR »
$27,157.00
25,000 shares
11-19-2021
Insider Buy
Matthew Pauls
CHIEF EXECUTIVE OFFICER
$1.10
CAGR »
$24,389.75
22,150 shares
11-22-2021
Insider Buy
David A. Ramsay
Director
$1.08
CAGR »
$215,392.60
200,000 shares
9-30-2021
Insider Buy
David A. Ramsay
Director
$1.29
CAGR »
$176,381.82
137,052 shares
8-18-2021
Insider Buy
David A. Ramsay
Director
$1.18
CAGR »
$115,180.95
97,290 shares
5-21-2021
Insider Buy
Matthew Pauls
CHIEF EXECUTIVE OFFICER
$1.63
CAGR »
$16,298.00
10,000 shares
4-19-2021
Insider Buy
Matthew Pauls
CHIEF EXECUTIVE OFFICER
$1.82
CAGR »
$49,870.74
27,400 shares
3-22-2021
Insider Buy
Matthew Pauls
CHIEF EXECUTIVE OFFICER
$2.07
CAGR »
$49,937.61
24,100 shares
3-15-2021
Insider Buy
Joseph S. McCracken
Director
$1.45
CAGR »
$99,999.25
68,965 shares
3-15-2021
Insider Buy
David L. Lowrance
CHIEF FINANCIAL OFFICER
$1.45
CAGR »
$19,999.85
13,793 shares
3-15-2021
Insider Buy
David A. Ramsay
Director
$1.45
CAGR »
$999,999.75
689,655 shares
2-22-2021
Insider Buy
Matthew Pauls
CHIEF EXECUTIVE OFFICER
$1.74
CAGR »
$50,038.45
28,700 shares
6-28-2019
Insider Buy
David A. Ramsay
Director
$2.37
CAGR »
$138,224.95
58,357 shares
6-18-2019
Insider Buy
David A. Ramsay
Director
$2.37
CAGR »
$95,355.25
40,215 shares
12-21-2018
Insider Buy
Robert N. Neville
Chief Executive Officer
$6.38
CAGR »
$149,993.78
23,517 shares
3-29-2018
Insider Buy
Yuri Pikover
Director
$9.00
CAGR »
$33,603.01
3,734 shares
10-27-2017
Insider Buy
Yuri Pikover
Director
$7.85
CAGR »
$392,500.00
50,000 shares
6-7-2017
Insider Buy
Joseph S. McCracken
Director
$4.75
CAGR »
$248,187.50
52,250 shares
6-7-2017
Insider Buy
David L. Lowrance
Chief Financial Officer
$4.75
CAGR »
$9,975.00
2,100 shares
6-7-2017
Insider Buy
Jaakko Taneli Jouhikainen
See Remarks
$4.75
CAGR »
$49,875.00
10,500 shares
6-7-2017
Insider Buy
Yuri Pikover
Director
$4.75
CAGR »
$475,000.00
100,000 shares
6-7-2017
Insider Buy
David A. Ramsay
Director
$4.75
CAGR »
$99,750.00
21,000 shares
6-7-2017
Insider Buy
Robert N. Neville
Chief Executive Officer
$4.75
CAGR »
$248,187.50
52,250 shares

Also See: Institutional Holders of SVRA
Also See: SEC filings

SVRA Performance Since Insider Purchase
Below we present the annualized performance delivered by SVRA stock since 7-17-2023 (the date of the most recent insider purchase). The performance of the investment from the time SVRA insider buying occurred is the ultimate test of whether insiders were right about SVRA being a good buy.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/18/2023
End date: 04/24/2024
Start price/share: $3.25
End price/share: $4.24
Dividends collected/share: $0.00
Total return: 30.46%
Annualized Gain: 39.57%
Starting investment: $10,000.00
Ending investment: $13,046.00
Years: 0.77

SVRA Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent SVRA insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding SVRA

SVRA Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.